Company newsCompany release
Hims & Hers Health HIMS
Hims & Hers Health appoints Andrew Huberman to board of directors
Huberman is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine.
GetSignal
Free on iOS and Android
On November 9, 2026, Hims & Hers Health announced the appointment of Andrew Huberman, Ph.D., to its Board of Directors.
Key facts
- Appointee
- Andrew Huberman, Ph.D.
- Board
- Board of Directors
- Announced
- November 9, 2026
Source: The company's release on Business Wire, November 9, 2026.
Written by GetSignal with AI from the company's press release.
Not investment advice.
More company news
Hims & Hers Health first, then the newest- Hims & Hers Health adds four partners to Hims & Hers Benefits
HIMS · Hims & Hers Health · Company release ·
- Hims & Hers Health launches injectable and oral testosterone therapies
HIMS · Hims & Hers Health · Company release ·
- Occidental signs long-term CO₂ offtake agreements with two companies
OXY · Occidental Petroleum · Company release ·